Verition Fund Management LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Verition Fund Management LLC

  • $17.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$83.14 - $145.99 $6.99 Million - $12.3 Million
84,094 Added 3509.77%
86,490 $12.6 Million
Q1 2022

May 13, 2022
SELL
$110.08 - $142.92 $577,039 - $749,186
-5,242 Reduced 68.63%
2,396 $284,000
Q4 2021

Feb 14, 2022
SELL
$99.73 - $148.48 $459,156 - $683,601
-4,604 Reduced 37.61%
7,638 $1.05 Million
Q3 2021

Nov 15, 2021
BUY
$98.85 - $138.91 $1.21 Million - $1.7 Million
12,242 New
12,242 $1.7 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.8B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email